Poland-based CDMO Mabion has completed the first GMP-compliant batch of [...]
Funding to advance EO2463 through Phase 1/2 and prepare for [...]
Commit Biologics has announced the formation of a Scientific Advisory [...]
Poolbeg Pharma has been granted Orphan Drug Designation (ODD) by [...]
SOTIO’s lead candidate, SOT109, is generating buzz in the ADC [...]